| Name | Title | Contact Details |
|---|
Meltwater helps companies make better, more informed decisions based on insights from the outside. We believe that business strategy will be increasingly shaped by insights from online data. Organizations will look outside, beyond their internal reporting systems to a world of data that is constantly growing and changing. Our customers use these insights to make timely decisions based on real-time analysis. More than 23,000 companies use the Meltwater media intelligence platform to stay on top of billions of online conversations, extract relevant insights, and use them to strategically manage their brand and stay ahead of their competition. With 50 offices on six continents, Meltwater is dedicated to personal, global service built on local expertise. Meltwater also operates the Meltwater Entrepreneurial School of Technology (MEST), a nonprofit organization devoted to nurturing future generations of entrepreneurs.
Taltopia.Com is a North Hollywood, CA-based company in the Software and Internet sector.
We are a Deaf-owned company that provides video relay service and other communication solutions.
Prezi`s virtual presentation, design, and video tools are the most engaging and effective way to share visual content online. Our flagship product, Prezi Video, brings your visuals on screen next to you while you present (unlike screen sharing, which hides you behind your slides). Now that we`re all connecting remotely, Prezi Video is exactly what people need for more meaningful interactions with their audience. Prezi Video works seamlessly with conferencing tools such as Zoom, Microsoft Teams, Google Meet, and Cisco Webex, and is perfect for sales pitches, business meetings, training sessions, online classes, and more. Designer templates and a massive image library for any topic make it easy to get started. Or, use the content you create using Prezi Present and Prezi Design, as well as your existing PowerPoint slides. Videos can be streamed live or recorded to share asynchronously.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.